Functional T Cell Reconstitution and Human Immunodeficiency Virus–1–Specific Cell‐Mediated Immunity during Highly Active Antiretroviral Therapy

Abstract

Lymphoproliferative responses (LPRs) to recall antigens (Ags) and human immunodeficiency virus type 1 (HIV-1) Gag and frequencies of circulating HIV-1—specific cytotoxic T lymphocyte precursors (CTLps) were measured in 12 patients undergoing highly active antiretroviral therapy (HAART) after long-standing HIV-1 infection. LPRs to at least 1 recall Ag became detectable or increased in all patients during HAART. No significant LPRs to Gag-p24 were observed, whereas 4 of 8 patients tested presented with Gag-p17—specific LPRs. HIV-1—specific CTLp frequencies became measurable or increased early during therapy in 6 of 10 patients tested and were maintained or decreased thereafter. Increasing HIV-1—specific CTLp frequencies were seen only in association with partial HAART failure in 1 patient. In conclusion, restoration of CD4⁺ T lymphocyte responsiveness to recall Ags is achieved during HAART. The data provide evidence for limited HIV-1—specific CD4⁺ memory T cells during advanced HIV-1 infection and suggest that both CD4⁺ and CD8⁺ HIV-1—specific T cells are poorly stimulated when viral load is suppressed.